FDA Advisory Committee supports second HPV vaccine

FDA advisory committee meeting on prasugrel for acute coronary syndromes.

that the benefits of prasugrel, relative to clopidogrel, can be attributed to more effective platelet inhibition from the higher active metabolite concentrations achieved through prasu grel’s loading dose and higher response rates with prasugrel’s 10-mg maintenance dose. Dr. Antman gave the core of the sponsors’ presentation— the results of TRITON-TIMI 38 (Trials to Assess Improvement in Therap...

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

During its February 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended 9-valent human papillomavirus (HPV) vaccine (9vHPV) (Gardasil 9, Merck and Co., Inc.) as one of three HPV vaccines that can be used for routine vaccination. HPV vaccine is recommended for routine vaccination at age 11 or 12 years. ACIP also recommends vaccination for females aged 13 through 26 ...

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).

On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. Cervarix is the second human papillomavirus (HPV) vaccine licensed for use in females in the United States. Quadrivalent HPV vaccine (HPV4; Gardasil, Merck & Co, Inc.) was licensed in 2006 for use in females age...

Immunization information systems: National Vaccine Advisory Committee progress report, 2007.

This article summarizes principal findings and recommendations of the National Vaccine Advisory Committee 2007 Progress report on Immunization Information Systems (IIS). Considerable progress has been made in each of the four primary objectives of the IIS: ensure appropriate protections of privacy and confidentiality for individuals and security for information included in the registry; ensure ...

Global Advisory Committee on Vaccine Safety, June 2012.